Taskin, B. D. Et Al. 2016. The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10 , 791-796.

Taskin, B. D., KULA, S., ERGÜN, M. A., Altun, D., Olgunturk, R., TUNAOĞLU, F. S., ... OĞUZ, A. D.(2016). The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, 791-796.

Taskin, Birce Et Al. "The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, 791-796, 2016

Taskin, Birce D. Et Al. "The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, pp.791-796, 2016

Taskin, B. D. Et Al. (2016) . "The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, pp.791-796.

@article{article, author={Birce Dilge Taskin Et Al. }, title={The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population}, journal={ANATOLIAN JOURNAL OF CARDIOLOGY}, year=2016, pages={791-796} }